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Diastolic wall strain (DWS) is a novel method that may be useful in estimating LV stiffness (related to myocardial fibrosis), while Doppler measures of diastolic function are more related to myocardial relaxation. 11, 12 DWS is clinically important as it may indicate early and subtle diastolic dysfunction during LV remodeling, before macroscopic geometric changes occur. 11, 13 Such dysfunction may be present even with "normal" LV diastolic function as measured by common Doppler parameters. 11 ,13 DWS appears to be relatively preload independent and is reproducible. 11, 14 It is easily measured echocardiographically as the difference between LV posterior wall thickness in systole and diastole, normalized to wall thickness in systole. This can be done simply in the two-dimensional parasternal long-axis view, as in our study (Figure 1 ), or with M-mode. Reduced diastolic wall thinning indicates decreased LV compliance and distensibility in keeping with linear elastic theory.
14 Systolic and diastolic indicators of LV performance on speckle tracking echocardiography (STE) have been shown to predict adverse outcomes in patients with severe AS. [15] [16] [17] [18] These indicators include global longitudinal, circumferential, and radial strain. DWS is significantly related to these measures of dysfunctional cardiac mechanics even after controlling for LVEF, LV mass index, mitral annular tissue velocity (e'), and LV filling pressures (E/e'). 19 The possible usefulness of DWS in patients with AS has not been previously reported. The aims of our study were to (1) discover whether DWS is reduced in patients with severe AS, which may indicate increased LV stiffness; (2) determine, whether possible, a prognostic cutoff value for DWS specific for identifying patients with severe AS at risk of death; and (3) investigate DWS in predicting mortality in patients with severe AS. 
| METHODS
| Study subjects and study design
| Echocardiographic acquisition
LVEF was obtained by the biplane Simpson's method. Mitral flow inflow velocities peak early, E, and peak late, A, were acquired in the apical four-chamber view. Diastolic function was assessed using the E/A ratio, and deceleration time. 20 Tissue Doppler velocities of the mitral annulus (septal and lateral e') were recorded from the apical four-chamber view to also determine diastolic function. 21 The LV filling pressure was estimated using the ratio of the trans-mitral early peak inflow velocity to the tissue Doppler velocity of the septal mitral annulus (E/e'). 22 Continuous-wave Doppler was used to measure aortic valve (AV) flow velocities at several transducer positions. 23 The peak and mean pressure gradients across the AV were calculated using the Diabetes mellitus, n (%) 24 (28) 10 (26) 14 (30) .67
Essential hypertension, n (%) 70 (81) 31 (80) 39 (83) .68
Hyperlipidemia, n (%) 44 (51) 17 (44) 27 (57) .20
Smoker, n (%) 5 (6) 4 (9) Symptoms-angina, shortness of breath, or dizziness/syncope, n (%)
25 (29) 11 (28) 14 (30 
| Intra-observer variability
All DWS measurements were easily performed in the two-dimensional parasternal long-axis view by one observer who was blinded to outcomes. These measurements were made on one beat and confirmed on three assessments. Five patients had suboptimal imaging for DWS measurements and were excluded from analysis. Paired t test was used to assess for intra-observer variability in a subset of 20 patients and was not found to be significant. 
| Statistical analysis
| RESULTS
Baseline characteristics for the group as a whole (n=86) are displayed in 
| DISCUSSION
To our knowledge, this is the first study to assess DWS in patients with severe AS and to describe its association with all-cause mortality in this population. The main findings of our study are (1) Asymptomatic patients with severe AS have an annual event rate
ranging from 20% to 43%. This is on top of a 1%-6% yearly risk of sudden death. 9,10,31,32 Consequently, there is much research seeking to identify asymptomatic patients with severe AS who are at highest risk.
These studies have utilized various echocardiographic measurements, cardiac magnetic resonance imaging assessing myocardial fibrosis, and biomarkers such as BNP.
9,10,31,32
In our study, we had the unique opportunity to observe the natural history of severe AS in a real world experience. We offered currently accepted AVI to all our patients. Many refused despite development of symptoms and education about the disease process, diagnosis, and prognosis. We left the final decision to them in respect of patient autonomy. Therefore, we observed a high event rate and many of our patients progressed to death.
DWS is a novel method described as a noninvasive and easily HFpEF. This remained true after adjusting for BNP, E/e�, LV mass index, pulmonary arterial pressure, age, and sex. In our study, we identified a DWS cutoff value of <0.25 as most specific in identifying patients with severe AS at highest risk of all-cause mortality.
Our study showed DWS does this independent of traditional clinical and echocardiographic parameters (including measures of diastolic function). DWS may detect LV stiffness before irreversible myocardial fibrosis has occurred in patients with severe AS: even if they remain asymptomatic.
Our study has certain limitations. It was a retrospective study in a single center. It is valuable in generating hypotheses for investigation in other populations. A majority of our patients were African American and therefore may not be applicable to other groups. Patients with a reduced LVEF were excluded, and our current findings may differ in that group. Finally, we also excluded patients who had AVI. It may be useful to assess DWS in patients before and after these interventions to see whether it remains predictive of mortality.
| CONCLUSION
DWS is a novel parameter which appears to have independent prognostic value in severe AS. It is easily measured and can be derived from two-dimensional or M-mode echocardiography (or potentially from CT and MRI). While these findings need to be verified in prospective studies, DWS may aid in clinical decision making, especially in high-risk patients, asymptomatic patients, and those with conflicting measures of AS severity. 
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